Related Experiment Video
Updated: Jan 9, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
Bridging Brain and Machine: A Neurocognitive Framework for Early Alzheimer's Detection Through Hierarchical Speech
IEEE Journal of Biomedical and Health Informatics
|December 10, 2025
Summary
We developed a novel AI framework to detect Alzheimer's disease (AD) from speech years before diagnosis. This neuro residual acoustic learning system achieves high accuracy, offering a promising tool for early AD detection.
Area of Science:
- Computational Neuroscience
- Artificial Intelligence in Healthcare
- Speech Signal Processing
Background:
- Alzheimer's disease (AD) impairs language networks, causing speech changes detectable early.
- Current automated speech analysis methods often miss subtle, diagnostically relevant temporal speech dynamics.
Purpose of the Study:
- To introduce the neuro residual acoustic learning (NeRAL) framework for early Alzheimer's disease detection using raw speech waveforms.
- To develop an end-to-end system inspired by biological auditory processing for enhanced speech analysis.
Main Methods:
- NeRAL utilizes acoustic-symbolic transformation, hierarchical temporal encoding with dilated convolutions, and attention mechanisms.
- The system processes raw audio waveforms, mimicking auditory cortex and prefrontal cortex functions.
- Evaluated on Mandarin (NCMMSC2021) and English (ADReSS) speech datasets.
Main Results:
- Achieved 86.55% accuracy on Mandarin extended utterances and 70.83% on English speech, outperforming existing methods.
- Demonstrated superior performance over multimodal and large language model approaches.
- Confusion matrix analysis identified specific misclassification patterns between AD and mild cognitive impairment, suggesting prodromal acoustic biomarkers.
Conclusions:
- The NeRAL framework offers a significant advancement in early Alzheimer's disease detection via speech analysis.
- Its biologically inspired architecture enhances the capture of subtle speech alterations.
- Results support the potential of acoustic biomarkers for non-invasive, early AD screening.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Higher Mental Functions of the Brain: Language
3.3K
Language is a system of communication that allows the expression of thoughts, ideas, and feelings. The brain processes language in both hemispheres.
Language formation and comprehension take place in the dominant hemisphere. The dominant hemisphere is responsible for understanding the meaning of spoken, written, or sign language, as well as the ability to communicate. For most people, the left hemisphere is the dominant one. The right hemisphere, then, gives tone and emotional context to the...
Language formation and comprehension take place in the dominant hemisphere. The dominant hemisphere is responsible for understanding the meaning of spoken, written, or sign language, as well as the ability to communicate. For most people, the left hemisphere is the dominant one. The right hemisphere, then, gives tone and emotional context to the...
3.3K
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752

